课题基金 / 基金详情

Cellular and Molecular Biology of Childhood Disease

Cellular and Molecular Biology of Childhood Disease
儿童疾病的细胞和分子生物学
批准号:
7625894
负责人:
Fielding Bruder STAPLETON
金额:
$43.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-11 至 2012-11-30

项目摘要

项目成果

Fielding Bruder STAPLETON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application seeks renewal of a highly successful CHRCDA, which supports the transitional training of pediatric scientists studying molecular and cellular aspects of childhood disease in the Department of Pediatrics, University of Washington School of Medicine. The objectives of this program are to identify, encourage, and support promising young pediatricians by facilitating their acquisition of the education, skills and experience required to initiate independent investigative careers. The new investigators and senior faculty advisors have laboratories at the University and its affiliated institutions: the Children's Hospital & Regional Medical Center and Fred Hutchinson Cancer Research Center, where the Department of Pediatrics has established clinical and research programs. The Program Director and members of the Internal Advisory Committee are available to advise at informal seminars and through an annual progress report and on a day-to-day basis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CELL AND MOLECULAR BIOLOGY OF DEVELOPMENT
  • 批准号:
    6826278
  • 项目类别:
  • 资助金额:
    $21.73万
  • 财政年份:
    2003
  • 负责人:
    Fielding Bruder STAPLETON
  • 依托单位:
CELL AND MOLECULAR BIOLOGY OF DEVELOPMENT
  • 批准号:
    6994417
  • 项目类别:
  • 资助金额:
    $42.37万
  • 财政年份:
    2003
  • 负责人:
    Fielding Bruder STAPLETON
  • 依托单位:
CELL AND MOLECULAR BIOLOGY OF DEVELOPMENT
  • 批准号:
    6736325
  • 项目类别:
  • 资助金额:
    $43.13万
  • 财政年份:
    2003
  • 负责人:
    Fielding Bruder STAPLETON
  • 依托单位:
Cellular and Molecular Biology of Childhood Disease
  • 批准号:
    8197166
  • 项目类别:
  • 资助金额:
    $35.49万
  • 财政年份:
    2003
  • 负责人:
    Fielding Bruder STAPLETON
  • 依托单位:
海外基金